Edinburgh Molecular Imaging Ltd - Product Pipeline Analysis, 2019 Update
October 2019
30
About the Report
About the Report
Summary
Edinburgh Molecular Imaging Ltd (EM Imaging) is a biotechnology company that develops optical molecular imaging technology. The company offers discovery and development of small molecules and peptides. It designs agents to improve the diagnosis and treatment of cancer and lung diseases. EM Imaging's agents include EMI-137 for CRC Lesion, EMI-200 for inflammation, EMI-300 and 350 for lung infection, EMI-400 for lung fibrosis, EMI-500 for breast cancer, and EMI-600 for single pulmonary nodules. The company develops optical imaging platform which shows the increased fluorescent signal from the optical agents on target engagement in a diseased patient. EM Imaging is headquartered in Edinburgh, the UK.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Edinburgh Molecular Imaging Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Products
Products
Edinburgh Molecular Imaging Ltd, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies
Companies
Alliance Medical Ltd
Imanova Ltd
Imaging Equipment Ltd
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Edinburgh Molecular Imaging Ltd Company Overview
Edinburgh Molecular Imaging Ltd Company Snapshot
Edinburgh Molecular Imaging Ltd Pipeline Products and Ongoing Clinical Trials Overview
Edinburgh Molecular Imaging Ltd-Pipeline Analysis Overview
Edinburgh Molecular Imaging Ltd-Key Facts
Edinburgh Molecular Imaging Ltd-Major Products and Services
Edinburgh Molecular Imaging Ltd Pipeline Products by Development Stage
Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials by Trial Status
Edinburgh Molecular Imaging Ltd Pipeline Products Overview
EMI-137
EMI-137 Product Overview
EMI-137 Clinical Trial
EMI-200
EMI-200 Product Overview
EMI-300/350
EMI-300/350 Product Overview
EMI-400
EMI-400 Product Overview
EMI-500
EMI-500 Product Overview
EMI-600
EMI-600 Product Overview
Edinburgh Molecular Imaging Ltd-Key Competitors
Edinburgh Molecular Imaging Ltd-Key Employees
Edinburgh Molecular Imaging Ltd-Locations And Subsidiaries
Head Office
Recent Developments
Edinburgh Molecular Imaging Ltd, Recent Developments
Nov 08, 2018: Edinburgh Molecular Imaging appoints Bernhard Sixt as new Chief Executive Officer
Oct 29, 2018: Edinburgh Molecular Imaging appoints new chairman
Sep 20, 2017: Edinburgh Molecular Imaging Commences Phase II European Cancer Trial
Mar 09, 2016: Edinburgh Molecular Imaging Awarded Innovate UK Grant To Qualify The Role Of EMI-137 In Colorectal Cancer Lesion Detection
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
Edinburgh Molecular Imaging Ltd Pipeline Products by Equipment Type
Edinburgh Molecular Imaging Ltd Pipeline Products by Development Stage
Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials by Trial Status
List of Table
List of Tables
Edinburgh Molecular Imaging Ltd Pipeline Products and Ongoing Clinical Trials Overview
Edinburgh Molecular Imaging Ltd Pipeline Products by Equipment Type
Edinburgh Molecular Imaging Ltd Pipeline Products by Indication
Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials by Trial Status
Edinburgh Molecular Imaging Ltd, Key Facts
Edinburgh Molecular Imaging Ltd, Major Products and Services
Edinburgh Molecular Imaging Ltd Number of Pipeline Products by Development Stage
Edinburgh Molecular Imaging Ltd Pipeline Products Summary by Development Stage
Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials by Trial Status
Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials Summary
EMI-137-Product Status
EMI-137-Product Description
EMI-137-Detection of Thyroid Cancer and Central Lymph Node Metastases Using EMI-137 Enhanced Molecular Fluorescent Guided Imaging: A Multicentre Feasibility and
EMI-137-Exploratory Study to Optically Visualise Activated Neutrophils and the Proto-oncogene, c-MET, in Lung Cancer Using DUAL Colour Fibre-based Endomicroscopy
EMI-137-Intraoperative Imaging of Colon Cancer Using a Fluorescent Peptide (EMI-137) Against the c-Met Receptor
EMI-137-Molecular Fluorescence Endoscopy for the Detection of (Pre) Malignant Lesions in Barrett's Esophagus Using a Fluorescent Tracer 'EMI-137' Targeting c-Met: A Single-center Feasibility and Safety Study
EMI-200-Product Status
EMI-200-Product Description
EMI-300/350-Product Status
EMI-300/350-Product Description
EMI-400-Product Status
EMI-400-Product Description
EMI-500-Product Status
EMI-500-Product Description
EMI-600-Product Status
EMI-600-Product Description
Edinburgh Molecular Imaging Ltd, Key Employees
Glossary
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.